

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 6.83019973 |
| 2 | nuclear pore organization (GO:0006999) | 5.70943746 |
| 3 | pore complex assembly (GO:0046931) | 4.90627519 |
| 4 | mitotic chromosome condensation (GO:0007076) | 4.89457969 |
| 5 | mitotic sister chromatid cohesion (GO:0007064) | 4.42543399 |
| 6 | homocysteine metabolic process (GO:0050667) | 4.34176686 |
| 7 | muscle filament sliding (GO:0030049) | 4.29068190 |
| 8 | actin-myosin filament sliding (GO:0033275) | 4.29068190 |
| 9 | protein carboxylation (GO:0018214) | 4.28165088 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.28165088 |
| 11 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.23041924 |
| 12 | DNA unwinding involved in DNA replication (GO:0006268) | 4.15856953 |
| 13 | lysine catabolic process (GO:0006554) | 4.14174541 |
| 14 | lysine metabolic process (GO:0006553) | 4.14174541 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 4.06549787 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.06549787 |
| 17 | tryptophan catabolic process (GO:0006569) | 4.06074152 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.06074152 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.06074152 |
| 20 | kynurenine metabolic process (GO:0070189) | 4.05791353 |
| 21 | aromatic amino acid family catabolic process (GO:0009074) | 4.03639871 |
| 22 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.96665936 |
| 23 | tryptophan metabolic process (GO:0006568) | 3.92680044 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 3.92073534 |
| 25 | regulation of protein activation cascade (GO:2000257) | 3.89177337 |
| 26 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.87533913 |
| 27 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.86606406 |
| 28 | L-phenylalanine metabolic process (GO:0006558) | 3.86606406 |
| 29 | urea cycle (GO:0000050) | 3.84887412 |
| 30 | urea metabolic process (GO:0019627) | 3.84887412 |
| 31 | ribosome assembly (GO:0042255) | 3.84810642 |
| 32 | phospholipid homeostasis (GO:0055091) | 3.74495558 |
| 33 | regulation of fibrinolysis (GO:0051917) | 3.70438669 |
| 34 | regulation of complement activation (GO:0030449) | 3.69387326 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 3.69152412 |
| 36 | positive regulation of fatty acid oxidation (GO:0046321) | 3.65705362 |
| 37 | complement activation, alternative pathway (GO:0006957) | 3.64143580 |
| 38 | actin-mediated cell contraction (GO:0070252) | 3.62707613 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56506822 |
| 40 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.52615534 |
| 41 | fatty acid transmembrane transport (GO:1902001) | 3.50000246 |
| 42 | regulation of RNA export from nucleus (GO:0046831) | 3.49427497 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 3.46791912 |
| 44 | cellular protein complex localization (GO:0034629) | 3.46184190 |
| 45 | bile acid biosynthetic process (GO:0006699) | 3.45648606 |
| 46 | glyoxylate metabolic process (GO:0046487) | 3.43349215 |
| 47 | carnitine shuttle (GO:0006853) | 3.42410516 |
| 48 | nitrogen cycle metabolic process (GO:0071941) | 3.42291012 |
| 49 | reverse cholesterol transport (GO:0043691) | 3.40963871 |
| 50 | IMP metabolic process (GO:0046040) | 3.40391669 |
| 51 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.40171617 |
| 52 | negative regulation of lipase activity (GO:0060192) | 3.37926276 |
| 53 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.34037939 |
| 54 | skeletal muscle contraction (GO:0003009) | 3.32091710 |
| 55 | triglyceride homeostasis (GO:0070328) | 3.30945681 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.30945681 |
| 57 | glycogen catabolic process (GO:0005980) | 3.28338198 |
| 58 | cellular hyperosmotic response (GO:0071474) | 3.25722337 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 3.23675672 |
| 60 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.23288510 |
| 61 | positive regulation of lipid catabolic process (GO:0050996) | 3.22179953 |
| 62 | DNA synthesis involved in DNA repair (GO:0000731) | 3.20008201 |
| 63 | negative regulation of protein activation cascade (GO:2000258) | 3.18281287 |
| 64 | formation of translation preinitiation complex (GO:0001731) | 3.18239769 |
| 65 | cysteine metabolic process (GO:0006534) | 3.17657087 |
| 66 | regulation of translational fidelity (GO:0006450) | 3.15674853 |
| 67 | plasma lipoprotein particle clearance (GO:0034381) | 3.15012868 |
| 68 | bile acid metabolic process (GO:0008206) | 3.11613856 |
| 69 | regulation of sequestering of triglyceride (GO:0010889) | 3.11552268 |
| 70 | fatty acid beta-oxidation (GO:0006635) | 3.10302385 |
| 71 | linoleic acid metabolic process (GO:0043651) | 3.08056996 |
| 72 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.05393876 |
| 73 | embryonic process involved in female pregnancy (GO:0060136) | 3.04740196 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 3.03069113 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 3.02895963 |
| 76 | actin filament-based movement (GO:0030048) | 3.02436835 |
| 77 | positive regulation of chromosome segregation (GO:0051984) | 3.02221563 |
| 78 | valine metabolic process (GO:0006573) | 3.02135604 |
| 79 | phospholipid efflux (GO:0033700) | 3.02133016 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.01018075 |
| 81 | glucan catabolic process (GO:0009251) | 3.00972510 |
| 82 | serine family amino acid catabolic process (GO:0009071) | 3.00355443 |
| 83 | plasma lipoprotein particle remodeling (GO:0034369) | 2.96623415 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 2.96623415 |
| 85 | macromolecular complex remodeling (GO:0034367) | 2.96623415 |
| 86 | fatty acid oxidation (GO:0019395) | 2.96588601 |
| 87 | sister chromatid cohesion (GO:0007062) | 2.96376472 |
| 88 | alpha-amino acid catabolic process (GO:1901606) | 2.95988878 |
| 89 | DNA duplex unwinding (GO:0032508) | 2.95885679 |
| 90 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.95720810 |
| 91 | regulation of translational termination (GO:0006449) | 2.95175545 |
| 92 | negative regulation of necroptotic process (GO:0060546) | 2.93252523 |
| 93 | regulation of sister chromatid cohesion (GO:0007063) | 2.91701709 |
| 94 | sarcomere organization (GO:0045214) | 2.91577530 |
| 95 | regulation of bile acid biosynthetic process (GO:0070857) | 2.90569143 |
| 96 | lipoprotein metabolic process (GO:0042157) | 2.89902805 |
| 97 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.89559094 |
| 98 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.89559094 |
| 99 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.89559094 |
| 100 | lipid oxidation (GO:0034440) | 2.88388657 |
| 101 | cellular polysaccharide catabolic process (GO:0044247) | 2.86634466 |
| 102 | protein complex localization (GO:0031503) | 2.86582499 |
| 103 | mitotic nuclear envelope disassembly (GO:0007077) | 2.84780105 |
| 104 | cellular modified amino acid catabolic process (GO:0042219) | 2.84151799 |
| 105 | indolalkylamine metabolic process (GO:0006586) | 2.83533753 |
| 106 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.83446042 |
| 107 | tyrosine metabolic process (GO:0006570) | 2.83146442 |
| 108 | regulation of fatty acid oxidation (GO:0046320) | 2.82132081 |
| 109 | plasma lipoprotein particle assembly (GO:0034377) | 2.81439881 |
| 110 | epoxygenase P450 pathway (GO:0019373) | 2.80973573 |
| 111 | nuclear envelope disassembly (GO:0051081) | 2.80848857 |
| 112 | membrane disassembly (GO:0030397) | 2.80848857 |
| 113 | iron ion import (GO:0097286) | 2.80317360 |
| 114 | COPI coating of Golgi vesicle (GO:0048205) | 2.79653105 |
| 115 | Golgi transport vesicle coating (GO:0048200) | 2.79653105 |
| 116 | nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289) | 2.79001434 |
| 117 | DNA geometric change (GO:0032392) | 2.78776840 |
| 118 | negative regulation of DNA repair (GO:0045738) | 2.78706061 |
| 119 | carnitine metabolic process (GO:0009437) | 2.78596896 |
| 120 | histone H3-K36 demethylation (GO:0070544) | 2.77502997 |
| 121 | aromatic amino acid family metabolic process (GO:0009072) | 2.76420854 |
| 122 | regulation of mitotic spindle organization (GO:0060236) | 2.75188814 |
| 123 | negative regulation of complement activation (GO:0045916) | 2.75177071 |
| 124 | cell-substrate adherens junction assembly (GO:0007045) | 2.75042112 |
| 125 | focal adhesion assembly (GO:0048041) | 2.75042112 |
| 126 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.74105725 |
| 127 | positive regulation of glycolytic process (GO:0045821) | 2.73975521 |
| 128 | fibrinolysis (GO:0042730) | 2.73842275 |
| 129 | cholesterol efflux (GO:0033344) | 2.73684895 |
| 130 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.73310068 |
| 131 | meiotic chromosome segregation (GO:0045132) | 2.73202651 |
| 132 | protein export from nucleus (GO:0006611) | 2.71623355 |
| 133 | short-chain fatty acid metabolic process (GO:0046459) | 2.71548190 |
| 134 | cellular glucuronidation (GO:0052695) | 2.71032208 |
| 135 | cellular biogenic amine catabolic process (GO:0042402) | 2.70461406 |
| 136 | amine catabolic process (GO:0009310) | 2.70461406 |
| 137 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.70354065 |
| 138 | coenzyme catabolic process (GO:0009109) | 2.70197078 |
| 139 | ethanol oxidation (GO:0006069) | 2.69971428 |
| 140 | drug catabolic process (GO:0042737) | 2.68850558 |
| 141 | bile acid and bile salt transport (GO:0015721) | 2.68457676 |
| 142 | DNA replication initiation (GO:0006270) | 2.67945304 |
| 143 | glucocorticoid biosynthetic process (GO:0006704) | 2.67507781 |
| 144 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.67466013 |
| 145 | non-recombinational repair (GO:0000726) | 2.67466013 |
| 146 | midgut development (GO:0007494) | 2.67099766 |
| 147 | chromosome condensation (GO:0030261) | 2.65625042 |
| 148 | cellular amino acid catabolic process (GO:0009063) | 2.65252514 |
| 149 | 4-hydroxyproline metabolic process (GO:0019471) | 2.65097474 |
| 150 | fatty acid catabolic process (GO:0009062) | 2.64996619 |
| 151 | carnitine transmembrane transport (GO:1902603) | 2.64948054 |
| 152 | protein localization to chromosome, centromeric region (GO:0071459) | 2.64236371 |
| 153 | regulation of cholesterol homeostasis (GO:2000188) | 2.63359642 |
| 154 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.63246121 |
| 155 | regulation of DNA endoreduplication (GO:0032875) | 2.62906291 |
| 156 | IMP biosynthetic process (GO:0006188) | 2.61532045 |
| 157 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.61418640 |
| 158 | negative regulation of sterol transport (GO:0032372) | 2.60312282 |
| 159 | negative regulation of cholesterol transport (GO:0032375) | 2.60312282 |
| 160 | regulation of necroptotic process (GO:0060544) | 2.58476154 |
| 161 | response to muscle activity (GO:0014850) | 2.57536341 |
| 162 | cell-substrate junction assembly (GO:0007044) | 2.56319111 |
| 163 | DNA conformation change (GO:0071103) | 2.55653344 |
| 164 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.55389273 |
| 165 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.55182101 |
| 166 | RNA stabilization (GO:0043489) | 2.54502800 |
| 167 | mRNA stabilization (GO:0048255) | 2.54502800 |
| 168 | DNA packaging (GO:0006323) | 2.51041306 |
| 169 | pinocytosis (GO:0006907) | 2.50214466 |
| 170 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.49121136 |
| 171 | polysaccharide catabolic process (GO:0000272) | 2.48293729 |
| 172 | DNA strand elongation (GO:0022616) | 2.44716199 |
| 173 | peptidyl-lysine dimethylation (GO:0018027) | 2.44113305 |
| 174 | NLS-bearing protein import into nucleus (GO:0006607) | 2.43752158 |
| 175 | nuclear envelope organization (GO:0006998) | 2.42333024 |
| 176 | regulation of relaxation of muscle (GO:1901077) | 2.40902560 |
| 177 | adherens junction assembly (GO:0034333) | 2.40859735 |
| 178 | glutamine metabolic process (GO:0006541) | 2.40386765 |
| 179 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.40131795 |
| 180 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.40035795 |
| 181 | mitochondrial DNA metabolic process (GO:0032042) | 2.38242036 |
| 182 | desmosome organization (GO:0002934) | 2.38021269 |
| 183 | ribosome biogenesis (GO:0042254) | 2.36922454 |
| 184 | hepatocyte differentiation (GO:0070365) | 2.35539724 |
| 185 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.35246846 |
| 186 | regulation of immune response to tumor cell (GO:0002837) | 2.34514581 |
| 187 | regulation of response to tumor cell (GO:0002834) | 2.34514581 |
| 188 | positive regulation of response to tumor cell (GO:0002836) | 2.34514581 |
| 189 | positive regulation of immune response to tumor cell (GO:0002839) | 2.34514581 |
| 190 | definitive hemopoiesis (GO:0060216) | 2.33693405 |
| 191 | positive regulation of myotube differentiation (GO:0010831) | 2.33366616 |
| 192 | NADH metabolic process (GO:0006734) | 2.33051126 |
| 193 | protein hydroxylation (GO:0018126) | 2.31921138 |
| 194 | folic acid metabolic process (GO:0046655) | 2.31697283 |
| 195 | actomyosin structure organization (GO:0031032) | 2.30294318 |
| 196 | cytokine production involved in immune response (GO:0002367) | 2.28828388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.53984895 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.02087168 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.44278139 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.89066824 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.81177845 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.70645024 |
| 7 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.54961746 |
| 8 | ZNF263_19887448_ChIP-Seq_K562_Human | 3.27373377 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.24786023 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.22404713 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.76477778 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.63616347 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.56242702 |
| 14 | MYC_22102868_ChIP-Seq_BL_Human | 2.54299457 |
| 15 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.52651774 |
| 16 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.40868083 |
| 17 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.34819863 |
| 18 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.27305885 |
| 19 | GATA1_22025678_ChIP-Seq_K562_Human | 2.26952716 |
| 20 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.10113789 |
| 21 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.07546942 |
| 22 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.07135766 |
| 23 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.01829330 |
| 24 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.99457982 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.96900931 |
| 26 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.88466703 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.87231957 |
| 28 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.86091671 |
| 29 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.83896966 |
| 30 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.82361948 |
| 31 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.76935714 |
| 32 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76846625 |
| 33 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.75966393 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.75545653 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.73463318 |
| 36 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.70088410 |
| 37 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.68810185 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.67819684 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.66493136 |
| 40 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.66396187 |
| 41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.66329144 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.65469308 |
| 43 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.61348303 |
| 44 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.60653778 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60143366 |
| 46 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.59794281 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59076295 |
| 48 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.58080882 |
| 49 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.57471479 |
| 50 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.56551790 |
| 51 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.50469567 |
| 52 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49419879 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.48147112 |
| 54 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47900999 |
| 55 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.46687853 |
| 56 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.45478254 |
| 57 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.45453487 |
| 58 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.44679280 |
| 59 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.44605744 |
| 60 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44591153 |
| 61 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44064633 |
| 62 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.43672052 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.43061101 |
| 64 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.41511703 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.40834229 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40396825 |
| 67 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40379083 |
| 68 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.38752709 |
| 69 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.38425822 |
| 70 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.38182961 |
| 71 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38004917 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.37990317 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36805602 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34650953 |
| 75 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.34447502 |
| 76 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.34271481 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31991797 |
| 78 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.30697628 |
| 79 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.30281494 |
| 80 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30052918 |
| 81 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.29404193 |
| 82 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.27613075 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.27602971 |
| 84 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24336227 |
| 85 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.24231020 |
| 86 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.23528224 |
| 87 | ATF3_27146783_Chip-Seq_COLON_Human | 1.23208169 |
| 88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.23156745 |
| 89 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.21476311 |
| 90 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.21384695 |
| 91 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.21051223 |
| 92 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20331208 |
| 93 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20130671 |
| 94 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.19676994 |
| 95 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.18979037 |
| 96 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18947154 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.18829118 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.18651420 |
| 99 | TP53_16413492_ChIP-PET_HCT116_Human | 1.18397177 |
| 100 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17461219 |
| 101 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17461219 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.16809907 |
| 103 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16781924 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16339924 |
| 105 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16229209 |
| 106 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.15059539 |
| 107 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14485518 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14128058 |
| 109 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.13448749 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13236159 |
| 111 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12579870 |
| 112 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.12339482 |
| 113 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.11587005 |
| 114 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.10615153 |
| 115 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10134356 |
| 116 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.09848437 |
| 117 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.08207285 |
| 118 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07764921 |
| 119 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07764921 |
| 120 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06619003 |
| 121 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06003636 |
| 122 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05750694 |
| 123 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05483185 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04298135 |
| 125 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.04100576 |
| 126 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03453013 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02756351 |
| 128 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.01862611 |
| 129 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.01456215 |
| 130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.01351120 |
| 131 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.01020942 |
| 132 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.00552931 |
| 133 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.00509152 |
| 134 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00455366 |
| 135 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.99870045 |
| 136 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99739719 |
| 137 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98158745 |
| 138 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97632164 |
| 139 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.96583893 |
| 140 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.96356148 |
| 141 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96095750 |
| 142 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.95851814 |
| 143 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94040157 |
| 144 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.93911026 |
| 145 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93905200 |
| 146 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93138476 |
| 147 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92969812 |
| 148 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.92934764 |
| 149 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.92430427 |
| 150 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92266291 |
| 151 | MAF_26560356_Chip-Seq_TH1_Human | 0.92084151 |
| 152 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91682650 |
| 153 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.91655328 |
| 154 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.91140296 |
| 155 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.91011619 |
| 156 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.90933300 |
| 157 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.90045214 |
| 158 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89856134 |
| 159 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89579977 |
| 160 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.89547698 |
| 161 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.89444043 |
| 162 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89329693 |
| 163 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.88763902 |
| 164 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88721716 |
| 165 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.88005612 |
| 166 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.87950887 |
| 167 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87782359 |
| 168 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.87365954 |
| 169 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.87186147 |
| 170 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86972664 |
| 171 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86884691 |
| 172 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.86867701 |
| 173 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.86867701 |
| 174 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86646807 |
| 175 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86011443 |
| 176 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.85904432 |
| 177 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84233881 |
| 178 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.83627755 |
| 179 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.82911962 |
| 180 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82188649 |
| 181 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.82066479 |
| 182 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81739586 |
| 183 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.81296607 |
| 184 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.81217689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.31816720 |
| 2 | MP0005360_urolithiasis | 4.75790695 |
| 3 | MP0005365_abnormal_bile_salt | 4.42917495 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.18777225 |
| 5 | MP0003252_abnormal_bile_duct | 3.70316150 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 3.16840270 |
| 7 | MP0003705_abnormal_hypodermis_morpholog | 3.05946988 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.02991659 |
| 9 | MP0004233_abnormal_muscle_weight | 2.86971384 |
| 10 | MP0008057_abnormal_DNA_replication | 2.67690768 |
| 11 | MP0003195_calcinosis | 2.62075042 |
| 12 | MP0003646_muscle_fatigue | 2.61354311 |
| 13 | MP0000569_abnormal_digit_pigmentation | 2.56426523 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.55508269 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.53746187 |
| 16 | MP0005083_abnormal_biliary_tract | 2.45066688 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.40943692 |
| 18 | MP0005670_abnormal_white_adipose | 2.25411169 |
| 19 | MP0010234_abnormal_vibrissa_follicle | 2.07533370 |
| 20 | MP0002009_preneoplasia | 2.07277283 |
| 21 | MP0003868_abnormal_feces_composition | 2.04844820 |
| 22 | MP0010094_abnormal_chromosome_stability | 1.91309604 |
| 23 | MP0003111_abnormal_nucleus_morphology | 1.90664023 |
| 24 | MP0003950_abnormal_plasma_membrane | 1.90341908 |
| 25 | MP0005275_abnormal_skin_tensile | 1.85479073 |
| 26 | MP0000747_muscle_weakness | 1.82029533 |
| 27 | MP0004957_abnormal_blastocyst_morpholog | 1.81931542 |
| 28 | MP0001666_abnormal_nutrient_absorption | 1.81282757 |
| 29 | * MP0004808_abnormal_hematopoietic_stem | 1.77797947 |
| 30 | MP0004130_abnormal_muscle_cell | 1.76201570 |
| 31 | MP0002396_abnormal_hematopoietic_system | 1.71078045 |
| 32 | MP0003693_abnormal_embryo_hatching | 1.70004934 |
| 33 | MP0009384_cardiac_valve_regurgitation | 1.67088456 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.61518012 |
| 35 | MP0002106_abnormal_muscle_physiology | 1.57192148 |
| 36 | MP0010368_abnormal_lymphatic_system | 1.54685760 |
| 37 | MP0005666_abnormal_adipose_tissue | 1.53721917 |
| 38 | MP0005503_abnormal_tendon_morphology | 1.51633249 |
| 39 | MP0004019_abnormal_vitamin_homeostasis | 1.51188252 |
| 40 | MP0000013_abnormal_adipose_tissue | 1.49282796 |
| 41 | MP0000609_abnormal_liver_physiology | 1.49125755 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.44390818 |
| 43 | MP0000750_abnormal_muscle_regeneration | 1.43415484 |
| 44 | MP0003279_aneurysm | 1.41571215 |
| 45 | MP0002118_abnormal_lipid_homeostasis | 1.40920617 |
| 46 | * MP0003077_abnormal_cell_cycle | 1.40169941 |
| 47 | MP0001730_embryonic_growth_arrest | 1.39587766 |
| 48 | MP0002332_abnormal_exercise_endurance | 1.38288322 |
| 49 | MP0009697_abnormal_copulation | 1.36567214 |
| 50 | MP0002060_abnormal_skin_morphology | 1.35703241 |
| 51 | MP0005409_darkened_coat_color | 1.34305408 |
| 52 | MP0004272_abnormal_basement_membrane | 1.32962821 |
| 53 | MP0000751_myopathy | 1.32026813 |
| 54 | MP0005647_abnormal_sex_gland | 1.30689894 |
| 55 | MP0005369_muscle_phenotype | 1.30658713 |
| 56 | MP0000427_abnormal_hair_cycle | 1.29645406 |
| 57 | MP0000749_muscle_degeneration | 1.27559698 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.24370740 |
| 59 | MP0003763_abnormal_thymus_physiology | 1.23269981 |
| 60 | MP0002928_abnormal_bile_duct | 1.22966893 |
| 61 | MP0004215_abnormal_myocardial_fiber | 1.22834438 |
| 62 | MP0005220_abnormal_exocrine_pancreas | 1.21296903 |
| 63 | MP0005332_abnormal_amino_acid | 1.21220780 |
| 64 | MP0003984_embryonic_growth_retardation | 1.18760128 |
| 65 | MP0001661_extended_life_span | 1.18708363 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 1.18443378 |
| 67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.17699435 |
| 68 | MP0005451_abnormal_body_composition | 1.17576120 |
| 69 | MP0003300_gastrointestinal_ulcer | 1.17487264 |
| 70 | MP0004147_increased_porphyrin_level | 1.16071750 |
| 71 | MP0003566_abnormal_cell_adhesion | 1.15997253 |
| 72 | MP0000350_abnormal_cell_proliferation | 1.15098704 |
| 73 | MP0002088_abnormal_embryonic_growth/wei | 1.14875563 |
| 74 | MP0001672_abnormal_embryogenesis/_devel | 1.13776494 |
| 75 | MP0005380_embryogenesis_phenotype | 1.13776494 |
| 76 | MP0002971_abnormal_brown_adipose | 1.13331999 |
| 77 | MP0002796_impaired_skin_barrier | 1.13126505 |
| 78 | MP0003283_abnormal_digestive_organ | 1.13071124 |
| 79 | MP0002086_abnormal_extraembryonic_tissu | 1.10453949 |
| 80 | MP0008007_abnormal_cellular_replicative | 1.09972061 |
| 81 | MP0004185_abnormal_adipocyte_glucose | 1.08613708 |
| 82 | MP0002896_abnormal_bone_mineralization | 1.08539125 |
| 83 | MP0004084_abnormal_cardiac_muscle | 1.07524121 |
| 84 | MP0005375_adipose_tissue_phenotype | 1.05315378 |
| 85 | MP0005257_abnormal_intraocular_pressure | 1.04869478 |
| 86 | MP0005334_abnormal_fat_pad | 1.04570739 |
| 87 | MP0001348_abnormal_lacrimal_gland | 1.03685205 |
| 88 | MP0005501_abnormal_skin_physiology | 1.03069861 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 1.01976591 |
| 90 | MP0002166_altered_tumor_susceptibility | 1.01572048 |
| 91 | MP0000579_abnormal_nail_morphology | 1.00546490 |
| 92 | MP0000767_abnormal_smooth_muscle | 0.99606964 |
| 93 | * MP0002080_prenatal_lethality | 0.99319915 |
| 94 | MP0008775_abnormal_heart_ventricle | 0.98626143 |
| 95 | MP0002108_abnormal_muscle_morphology | 0.98421149 |
| 96 | MP0001697_abnormal_embryo_size | 0.98259395 |
| 97 | MP0000383_abnormal_hair_follicle | 0.97120657 |
| 98 | MP0003045_fibrosis | 0.95854564 |
| 99 | MP0004087_abnormal_muscle_fiber | 0.95294307 |
| 100 | MP0002269_muscular_atrophy | 0.94688961 |
| 101 | MP0002168_other_aberrant_phenotype | 0.94622119 |
| 102 | MP0003806_abnormal_nucleotide_metabolis | 0.94333104 |
| 103 | MP0010630_abnormal_cardiac_muscle | 0.93275548 |
| 104 | MP0003191_abnormal_cellular_cholesterol | 0.93239824 |
| 105 | MP0005330_cardiomyopathy | 0.90773354 |
| 106 | MP0001958_emphysema | 0.90403630 |
| 107 | MP0005621_abnormal_cell_physiology | 0.89826438 |
| 108 | MP0009672_abnormal_birth_weight | 0.89691630 |
| 109 | MP0009840_abnormal_foam_cell | 0.88368149 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 0.87986132 |
| 111 | MP0002972_abnormal_cardiac_muscle | 0.87567982 |
| 112 | MP0000733_abnormal_muscle_development | 0.86527658 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.83965247 |
| 114 | MP0006054_spinal_hemorrhage | 0.83695489 |
| 115 | MP0009764_decreased_sensitivity_to | 0.83618190 |
| 116 | MP0002697_abnormal_eye_size | 0.82860691 |
| 117 | MP0001243_abnormal_dermal_layer | 0.82388169 |
| 118 | MP0005248_abnormal_Harderian_gland | 0.80691021 |
| 119 | MP0000428_abnormal_craniofacial_morphol | 0.80682105 |
| 120 | MP0002254_reproductive_system_inflammat | 0.80171046 |
| 121 | MP0008932_abnormal_embryonic_tissue | 0.79929606 |
| 122 | MP0005023_abnormal_wound_healing | 0.79861675 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.76340988 |
| 124 | MP0001216_abnormal_epidermal_layer | 0.76167388 |
| 125 | MP0004197_abnormal_fetal_growth/weight/ | 0.76069823 |
| 126 | MP0000313_abnormal_cell_death | 0.76046921 |
| 127 | MP0002084_abnormal_developmental_patter | 0.74948807 |
| 128 | MP0010678_abnormal_skin_adnexa | 0.74622919 |
| 129 | MP0005076_abnormal_cell_differentiation | 0.74446928 |
| 130 | MP0004484_altered_response_of | 0.74271151 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.74063422 |
| 132 | MP0002128_abnormal_blood_circulation | 0.73950763 |
| 133 | MP0001849_ear_inflammation | 0.73506145 |
| 134 | * MP0008058_abnormal_DNA_repair | 0.73348127 |
| 135 | MP0004036_abnormal_muscle_relaxation | 0.72749880 |
| 136 | MP0002006_tumorigenesis | 0.72575339 |
| 137 | MP0004145_abnormal_muscle_electrophysio | 0.71516654 |
| 138 | MP0005620_abnormal_muscle_contractility | 0.71267361 |
| 139 | MP0000598_abnormal_liver_morphology | 0.70499644 |
| 140 | MP0002234_abnormal_pharynx_morphology | 0.69764696 |
| 141 | MP0003828_pulmonary_edema | 0.69537310 |
| 142 | MP0000759_abnormal_skeletal_muscle | 0.69258921 |
| 143 | MP0009115_abnormal_fat_cell | 0.69073229 |
| 144 | MP0005384_cellular_phenotype | 0.68659172 |
| 145 | MP0005187_abnormal_penis_morphology | 0.68252650 |
| 146 | MP0009763_increased_sensitivity_to | 0.67144003 |
| 147 | MP0001544_abnormal_cardiovascular_syste | 0.67142740 |
| 148 | MP0005385_cardiovascular_system_phenoty | 0.67142740 |
| 149 | MP0006138_congestive_heart_failure | 0.65027881 |
| 150 | MP0003011_delayed_dark_adaptation | 0.64182231 |
| 151 | MP0003115_abnormal_respiratory_system | 0.63411934 |
| 152 | MP0003941_abnormal_skin_development | 0.63101699 |
| 153 | MP0010307_abnormal_tumor_latency | 0.62995499 |
| 154 | MP0003091_abnormal_cell_migration | 0.61617952 |
| 155 | MP0001915_intracranial_hemorrhage | 0.60370302 |
| 156 | MP0009703_decreased_birth_body | 0.60342050 |
| 157 | MP0000266_abnormal_heart_morphology | 0.58758063 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nemaline bodies (HP:0003798) | 6.21729206 |
| 2 | Muscle fiber inclusion bodies (HP:0100299) | 6.11564048 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.04016761 |
| 4 | Exercise-induced myalgia (HP:0003738) | 4.65765615 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.50741662 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.13535768 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.07555104 |
| 8 | Exercise-induced muscle cramps (HP:0003710) | 3.83117193 |
| 9 | Xanthomatosis (HP:0000991) | 3.71500661 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.66839427 |
| 11 | Hypoalphalipoproteinemia (HP:0003233) | 3.62695414 |
| 12 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.52974639 |
| 13 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.42278127 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.38277548 |
| 15 | Joint hemorrhage (HP:0005261) | 3.29389600 |
| 16 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.25837831 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 3.20782193 |
| 18 | Rhabdomyolysis (HP:0003201) | 3.20323170 |
| 19 | EMG: myopathic abnormalities (HP:0003458) | 3.14599871 |
| 20 | Ketosis (HP:0001946) | 3.13062966 |
| 21 | Distal arthrogryposis (HP:0005684) | 3.11316891 |
| 22 | Epidermoid cyst (HP:0200040) | 3.10380813 |
| 23 | Progressive muscle weakness (HP:0003323) | 3.10253405 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.10153216 |
| 25 | Calcaneovalgus deformity (HP:0001848) | 3.04189649 |
| 26 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.02896479 |
| 27 | Subaortic stenosis (HP:0001682) | 3.02896479 |
| 28 | Hypolipoproteinemia (HP:0010981) | 3.02153734 |
| 29 | Complement deficiency (HP:0004431) | 3.00420434 |
| 30 | Round ear (HP:0100830) | 3.00029797 |
| 31 | Myopathic facies (HP:0002058) | 2.99650848 |
| 32 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.97925434 |
| 33 | Protrusio acetabuli (HP:0003179) | 2.96575237 |
| 34 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.82540703 |
| 35 | Increased variability in muscle fiber diameter (HP:0003557) | 2.82319738 |
| 36 | Neck muscle weakness (HP:0000467) | 2.82250658 |
| 37 | Hepatocellular carcinoma (HP:0001402) | 2.81509180 |
| 38 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.81100458 |
| 39 | Increased connective tissue (HP:0009025) | 2.80037045 |
| 40 | Abnormality of the calcaneus (HP:0008364) | 2.78144913 |
| 41 | Distal lower limb amyotrophy (HP:0008944) | 2.77366868 |
| 42 | Ulnar deviation of the wrist (HP:0003049) | 2.76626433 |
| 43 | Myocardial infarction (HP:0001658) | 2.75592571 |
| 44 | Hypobetalipoproteinemia (HP:0003563) | 2.70421298 |
| 45 | Deformed tarsal bones (HP:0008119) | 2.70272752 |
| 46 | Ketoacidosis (HP:0001993) | 2.67629304 |
| 47 | Rimmed vacuoles (HP:0003805) | 2.67553041 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.63107319 |
| 49 | Poikilocytosis (HP:0004447) | 2.62425821 |
| 50 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.62181101 |
| 51 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.61497036 |
| 52 | Osteolytic defects of the hand bones (HP:0009699) | 2.61497036 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.60601098 |
| 54 | Muscle fiber splitting (HP:0003555) | 2.56284230 |
| 55 | Renal cortical cysts (HP:0000803) | 2.55883710 |
| 56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.55483415 |
| 57 | Premature rupture of membranes (HP:0001788) | 2.54043931 |
| 58 | Dysmetric saccades (HP:0000641) | 2.52937231 |
| 59 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.51736206 |
| 60 | Distal lower limb muscle weakness (HP:0009053) | 2.46845075 |
| 61 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.45488063 |
| 62 | Achilles tendon contracture (HP:0001771) | 2.45373565 |
| 63 | Abnormality of the calf musculature (HP:0001430) | 2.44714882 |
| 64 | Type 1 muscle fiber predominance (HP:0003803) | 2.44502890 |
| 65 | Right ventricular cardiomyopathy (HP:0011663) | 2.43297731 |
| 66 | Mesomelia (HP:0003027) | 2.43079887 |
| 67 | Spinal rigidity (HP:0003306) | 2.40036713 |
| 68 | Hyperammonemia (HP:0001987) | 2.39002784 |
| 69 | Calf muscle hypertrophy (HP:0008981) | 2.36009603 |
| 70 | Cardiovascular calcification (HP:0011915) | 2.34637414 |
| 71 | Hyperglycemia (HP:0003074) | 2.31054190 |
| 72 | Broad metatarsal (HP:0001783) | 2.30526722 |
| 73 | Hypercholesterolemia (HP:0003124) | 2.29651807 |
| 74 | Renovascular hypertension (HP:0100817) | 2.29452959 |
| 75 | Turricephaly (HP:0000262) | 2.25634332 |
| 76 | Shoulder girdle muscle weakness (HP:0003547) | 2.25180430 |
| 77 | Conjugated hyperbilirubinemia (HP:0002908) | 2.24437145 |
| 78 | Enlarged kidneys (HP:0000105) | 2.24185212 |
| 79 | Skin nodule (HP:0200036) | 2.23695513 |
| 80 | Mitral stenosis (HP:0001718) | 2.22688422 |
| 81 | Difficulty running (HP:0009046) | 2.22132523 |
| 82 | Reticulocytosis (HP:0001923) | 2.21464025 |
| 83 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.19634324 |
| 84 | Abnormality of the Achilles tendon (HP:0005109) | 2.18709991 |
| 85 | Progressive external ophthalmoplegia (HP:0000590) | 2.16808643 |
| 86 | Lymphangioma (HP:0100764) | 2.16352828 |
| 87 | Acanthocytosis (HP:0001927) | 2.16192513 |
| 88 | Elbow flexion contracture (HP:0002987) | 2.15997497 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.15285087 |
| 90 | Abnormality of methionine metabolism (HP:0010901) | 2.14176074 |
| 91 | Ankyloglossia (HP:0010296) | 2.14003779 |
| 92 | Hyperbilirubinemia (HP:0002904) | 2.13127525 |
| 93 | Asymmetric septal hypertrophy (HP:0001670) | 2.12685614 |
| 94 | Scapular winging (HP:0003691) | 2.11282921 |
| 95 | Limb-girdle muscle weakness (HP:0003325) | 2.11266582 |
| 96 | Difficulty climbing stairs (HP:0003551) | 2.10647665 |
| 97 | Pelvic girdle muscle weakness (HP:0003749) | 2.10592725 |
| 98 | Lower limb amyotrophy (HP:0007210) | 2.10227527 |
| 99 | Selective tooth agenesis (HP:0001592) | 2.09332797 |
| 100 | Abnormality of nucleobase metabolism (HP:0010932) | 2.09326421 |
| 101 | Aneurysm (HP:0002617) | 2.09255261 |
| 102 | Chorioretinal atrophy (HP:0000533) | 2.08863812 |
| 103 | Aortic aneurysm (HP:0004942) | 2.07859805 |
| 104 | Spastic diplegia (HP:0001264) | 2.07390882 |
| 105 | Upper limb muscle weakness (HP:0003484) | 2.07184034 |
| 106 | Slender build (HP:0001533) | 2.06736486 |
| 107 | Vascular calcification (HP:0004934) | 2.05354077 |
| 108 | Ventricular tachycardia (HP:0004756) | 2.03749094 |
| 109 | Hyperglycinuria (HP:0003108) | 2.02106962 |
| 110 | Hypoplastic ischia (HP:0003175) | 2.01628305 |
| 111 | Cerebral aneurysm (HP:0004944) | 2.01231292 |
| 112 | Long toe (HP:0010511) | 2.00776754 |
| 113 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.00716988 |
| 114 | Fragile skin (HP:0001030) | 2.00203386 |
| 115 | Hyporeflexia of lower limbs (HP:0002600) | 1.99973900 |
| 116 | Deep philtrum (HP:0002002) | 1.99666246 |
| 117 | Abnormality of complement system (HP:0005339) | 1.99521626 |
| 118 | Bundle branch block (HP:0011710) | 1.98351678 |
| 119 | Lipoatrophy (HP:0100578) | 1.96555407 |
| 120 | Areflexia of lower limbs (HP:0002522) | 1.96396060 |
| 121 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.95888662 |
| 122 | Fatigue (HP:0012378) | 1.95156677 |
| 123 | Pigmentary retinal degeneration (HP:0001146) | 1.93915920 |
| 124 | Abnormality of oral frenula (HP:0000190) | 1.92795543 |
| 125 | Syringomyelia (HP:0003396) | 1.92240856 |
| 126 | Spinal cord lesions (HP:0100561) | 1.92240856 |
| 127 | Generalized amyotrophy (HP:0003700) | 1.91751284 |
| 128 | Hypochromic microcytic anemia (HP:0004840) | 1.91505536 |
| 129 | Abnormality of purine metabolism (HP:0004352) | 1.91245601 |
| 130 | Hydroxyprolinuria (HP:0003080) | 1.91138690 |
| 131 | Abnormality of proline metabolism (HP:0010907) | 1.91138690 |
| 132 | Myoglobinuria (HP:0002913) | 1.90929237 |
| 133 | Abnormality of the ischium (HP:0003174) | 1.90559153 |
| 134 | Microvesicular hepatic steatosis (HP:0001414) | 1.90506096 |
| 135 | Congenital stationary night blindness (HP:0007642) | 1.90424229 |
| 136 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.90269281 |
| 137 | Abnormality of glycine metabolism (HP:0010895) | 1.89353876 |
| 138 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.89353876 |
| 139 | Atrophic scars (HP:0001075) | 1.89081626 |
| 140 | Metatarsus adductus (HP:0001840) | 1.87767797 |
| 141 | Abnormality of the renal cortex (HP:0011035) | 1.87109036 |
| 142 | Sparse lateral eyebrow (HP:0005338) | 1.86792249 |
| 143 | Ankle contracture (HP:0006466) | 1.85994765 |
| 144 | Entropion (HP:0000621) | 1.83958255 |
| 145 | Muscle stiffness (HP:0003552) | 1.83542994 |
| 146 | Cholelithiasis (HP:0001081) | 1.83071638 |
| 147 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.82337488 |
| 148 | Fat malabsorption (HP:0002630) | 1.81938984 |
| 149 | Generalized muscle weakness (HP:0003324) | 1.81249606 |
| 150 | Elfin facies (HP:0004428) | 1.80893608 |
| 151 | Aortic dissection (HP:0002647) | 1.80390590 |
| 152 | Ectopia lentis (HP:0001083) | 1.79422637 |
| 153 | Mitral valve prolapse (HP:0001634) | 1.78940789 |
| 154 | Limb-girdle muscle atrophy (HP:0003797) | 1.78675130 |
| 155 | Esophageal varix (HP:0002040) | 1.78549709 |
| 156 | Asymmetry of the thorax (HP:0001555) | 1.77190129 |
| 157 | Dilated cardiomyopathy (HP:0001644) | 1.76480799 |
| 158 | Vertebral compression fractures (HP:0002953) | 1.75939465 |
| 159 | Sudden death (HP:0001699) | 1.75086246 |
| 160 | Symptomatic seizures (HP:0011145) | 1.74948835 |
| 161 | Abnormality of serum amino acid levels (HP:0003112) | 1.74087846 |
| 162 | Flat acetabular roof (HP:0003180) | 1.73913790 |
| 163 | Bell-shaped thorax (HP:0001591) | 1.73550705 |
| 164 | Hyperglycinemia (HP:0002154) | 1.73271851 |
| 165 | Abnormal gallbladder morphology (HP:0012437) | 1.72483015 |
| 166 | Bladder diverticulum (HP:0000015) | 1.71954032 |
| 167 | Enlarged penis (HP:0000040) | 1.69662514 |
| 168 | Trismus (HP:0000211) | 1.68955228 |
| 169 | Osteomalacia (HP:0002749) | 1.68822840 |
| 170 | Dislocated radial head (HP:0003083) | 1.68608847 |
| 171 | Subacute progressive viral hepatitis (HP:0006572) | 1.68072904 |
| 172 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.67681494 |
| 173 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.67681494 |
| 174 | Wormian bones (HP:0002645) | 1.66487281 |
| 175 | Hyperkalemia (HP:0002153) | 1.65281593 |
| 176 | Hyperacusis (HP:0010780) | 1.64449325 |
| 177 | Acute myeloid leukemia (HP:0004808) | 1.60976169 |
| 178 | Malignant hyperthermia (HP:0002047) | 1.60847931 |
| 179 | Abnormality of the tricuspid valve (HP:0001702) | 1.59107106 |
| 180 | Natal tooth (HP:0000695) | 1.55755620 |
| 181 | Advanced eruption of teeth (HP:0006288) | 1.54641200 |
| 182 | Abnormality of the salivary glands (HP:0010286) | 1.54467554 |
| 183 | Breech presentation (HP:0001623) | 1.53915974 |
| 184 | Short nail (HP:0001799) | 1.52389518 |
| 185 | Deviation of the thumb (HP:0009603) | 1.52143438 |
| 186 | Heterotopia (HP:0002282) | 1.51687452 |
| 187 | Bulbar palsy (HP:0001283) | 1.51663189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 3.76599694 |
| 2 | SIK1 | 3.72850067 |
| 3 | INSRR | 3.68104362 |
| 4 | TTN | 3.03177982 |
| 5 | PKN2 | 2.82300968 |
| 6 | PBK | 2.81156581 |
| 7 | CAMK1D | 2.76230216 |
| 8 | TRIB3 | 2.57067520 |
| 9 | PRPF4B | 2.16338696 |
| 10 | FRK | 2.13445694 |
| 11 | CAMK1G | 2.12999803 |
| 12 | NEK1 | 2.00765290 |
| 13 | SMG1 | 1.97433852 |
| 14 | CDK12 | 1.93171988 |
| 15 | PIK3CG | 1.91958059 |
| 16 | PDGFRA | 1.74994653 |
| 17 | FLT3 | 1.74334681 |
| 18 | EIF2AK2 | 1.73912385 |
| 19 | RPS6KB2 | 1.69058990 |
| 20 | PTK6 | 1.67768253 |
| 21 | BCKDK | 1.67232147 |
| 22 | NEK9 | 1.62583649 |
| 23 | FGFR4 | 1.62226900 |
| 24 | TSSK6 | 1.60842902 |
| 25 | TAOK3 | 1.60713292 |
| 26 | ERN1 | 1.60483517 |
| 27 | RIPK1 | 1.59596791 |
| 28 | ZAK | 1.57161102 |
| 29 | OBSCN | 1.57021914 |
| 30 | EIF2AK1 | 1.46196226 |
| 31 | JAK1 | 1.43581552 |
| 32 | PRKAA2 | 1.40917001 |
| 33 | STK3 | 1.40832775 |
| 34 | CDC7 | 1.31084524 |
| 35 | MAP3K7 | 1.31066714 |
| 36 | STK24 | 1.28240608 |
| 37 | DDR2 | 1.27597893 |
| 38 | CDK6 | 1.21067050 |
| 39 | FER | 1.19626265 |
| 40 | MTOR | 1.19045099 |
| 41 | BRSK2 | 1.18630494 |
| 42 | LATS2 | 1.16992772 |
| 43 | MST1R | 1.16257238 |
| 44 | PIK3CA | 1.16059554 |
| 45 | GRK1 | 1.14923127 |
| 46 | EIF2AK3 | 1.14763807 |
| 47 | MAP3K13 | 1.10531752 |
| 48 | AKT3 | 1.10174436 |
| 49 | STK38L | 1.09554459 |
| 50 | TGFBR2 | 1.08143456 |
| 51 | NME2 | 1.08004612 |
| 52 | NUAK1 | 1.07857746 |
| 53 | PTK2 | 1.07739330 |
| 54 | PRKAA1 | 1.05193046 |
| 55 | PDK4 | 1.05118159 |
| 56 | PDK3 | 1.05118159 |
| 57 | BRD4 | 1.01930909 |
| 58 | MAP3K14 | 0.98997987 |
| 59 | DMPK | 0.95835558 |
| 60 | ERBB2 | 0.92626262 |
| 61 | MAP3K8 | 0.89974679 |
| 62 | MKNK1 | 0.89116836 |
| 63 | AKT2 | 0.88015129 |
| 64 | FGFR2 | 0.85696462 |
| 65 | EPHA3 | 0.85301959 |
| 66 | PAK2 | 0.85170900 |
| 67 | SRPK1 | 0.84255917 |
| 68 | SGK3 | 0.82777485 |
| 69 | LMTK2 | 0.82266480 |
| 70 | MAP3K10 | 0.81428342 |
| 71 | KSR2 | 0.81215616 |
| 72 | MAPK11 | 0.80790320 |
| 73 | FGFR1 | 0.76110078 |
| 74 | PDGFRB | 0.74468689 |
| 75 | CDK8 | 0.74136941 |
| 76 | BRAF | 0.72920189 |
| 77 | CHEK1 | 0.72489816 |
| 78 | RPS6KA4 | 0.70740914 |
| 79 | SIK2 | 0.70613354 |
| 80 | FGFR3 | 0.69711213 |
| 81 | DYRK1B | 0.68421559 |
| 82 | SGK2 | 0.68326689 |
| 83 | MAP3K2 | 0.67746195 |
| 84 | MELK | 0.67584438 |
| 85 | CDK7 | 0.67356152 |
| 86 | RPS6KB1 | 0.67000658 |
| 87 | PNCK | 0.66600025 |
| 88 | ERBB4 | 0.65746679 |
| 89 | ICK | 0.65014921 |
| 90 | CDC42BPA | 0.64659534 |
| 91 | MAP3K1 | 0.63077775 |
| 92 | TYK2 | 0.62787445 |
| 93 | EEF2K | 0.62527878 |
| 94 | PAK4 | 0.60636148 |
| 95 | PAK3 | 0.60478291 |
| 96 | NEK2 | 0.60130862 |
| 97 | RAF1 | 0.59927568 |
| 98 | MAP3K6 | 0.59650652 |
| 99 | STK4 | 0.59419422 |
| 100 | MET | 0.59407792 |
| 101 | MOS | 0.59124309 |
| 102 | CDK9 | 0.58466241 |
| 103 | AURKB | 0.56110748 |
| 104 | SGK1 | 0.55863011 |
| 105 | TAF1 | 0.54743682 |
| 106 | CLK1 | 0.52529200 |
| 107 | CDK4 | 0.51895147 |
| 108 | TTK | 0.51871186 |
| 109 | TIE1 | 0.50857030 |
| 110 | CHEK2 | 0.50329053 |
| 111 | MAP2K3 | 0.50206685 |
| 112 | STK38 | 0.49790856 |
| 113 | CAMK4 | 0.49056588 |
| 114 | WNK1 | 0.49039432 |
| 115 | RET | 0.48760036 |
| 116 | JAK2 | 0.48440849 |
| 117 | PLK1 | 0.47356619 |
| 118 | MAPK12 | 0.46008172 |
| 119 | CHUK | 0.45059774 |
| 120 | SCYL2 | 0.44923689 |
| 121 | TAOK2 | 0.44032212 |
| 122 | IRAK3 | 0.43905994 |
| 123 | BMX | 0.43452946 |
| 124 | YES1 | 0.42956676 |
| 125 | MAP2K2 | 0.41883485 |
| 126 | AKT1 | 0.41868987 |
| 127 | EPHA2 | 0.41670528 |
| 128 | WEE1 | 0.41483098 |
| 129 | DAPK2 | 0.41368791 |
| 130 | EPHB2 | 0.40799518 |
| 131 | TRPM7 | 0.39870704 |
| 132 | NLK | 0.39685876 |
| 133 | PHKG1 | 0.39408452 |
| 134 | PHKG2 | 0.39408452 |
| 135 | MAP3K3 | 0.39355111 |
| 136 | MAPK7 | 0.39135547 |
| 137 | MAP2K1 | 0.39019582 |
| 138 | STK10 | 0.38950486 |
| 139 | PDK2 | 0.38264667 |
| 140 | PRKACG | 0.37564727 |
| 141 | ROCK1 | 0.37326655 |
| 142 | MAP3K5 | 0.36880419 |
| 143 | ZAP70 | 0.36823538 |
| 144 | ATR | 0.36420568 |
| 145 | BUB1 | 0.36410166 |
| 146 | TGFBR1 | 0.35540194 |
| 147 | RPS6KC1 | 0.34993644 |
| 148 | RPS6KL1 | 0.34993644 |
| 149 | MAPK10 | 0.34704714 |
| 150 | RPS6KA1 | 0.34462112 |
| 151 | MAP2K4 | 0.33428561 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.28998717 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.03474728 |
| 3 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71891614 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.65713519 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.47941779 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.47803768 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.42966769 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.37726717 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.37654972 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32919395 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.32067441 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 2.24936328 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24093003 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.07962885 |
| 15 | Thyroid cancer_Homo sapiens_hsa05216 | 2.06944622 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.93442768 |
| 17 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.91734106 |
| 18 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.88544686 |
| 19 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88204833 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87912235 |
| 21 | ABC transporters_Homo sapiens_hsa02010 | 1.87390731 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81673837 |
| 23 | Cell cycle_Homo sapiens_hsa04110 | 1.80802214 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.79088532 |
| 25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74329683 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.72151405 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.67499080 |
| 28 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64793231 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.64099695 |
| 30 | Peroxisome_Homo sapiens_hsa04146 | 1.60420853 |
| 31 | RNA transport_Homo sapiens_hsa03013 | 1.59825532 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.59639867 |
| 33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.53177927 |
| 34 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.51620201 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.50917405 |
| 36 | Mismatch repair_Homo sapiens_hsa03430 | 1.44630448 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.44157620 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.40550728 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.40329511 |
| 40 | Retinol metabolism_Homo sapiens_hsa00830 | 1.39077944 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.35127392 |
| 42 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.34581410 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.33467158 |
| 44 | Endometrial cancer_Homo sapiens_hsa05213 | 1.21614704 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.21472836 |
| 46 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17595558 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16083555 |
| 48 | * Nucleotide excision repair_Homo sapiens_hsa03420 | 1.15607923 |
| 49 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.15010224 |
| 50 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.14284530 |
| 51 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.12156686 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10532609 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.10406423 |
| 54 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.06614650 |
| 55 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.04512830 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03935304 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03030854 |
| 58 | Insulin resistance_Homo sapiens_hsa04931 | 1.01807753 |
| 59 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99245709 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97769788 |
| 61 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.94986504 |
| 62 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.93913205 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.93690053 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93231181 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.92849399 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.92340271 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91930172 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91232530 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90818389 |
| 70 | Spliceosome_Homo sapiens_hsa03040 | 0.90269125 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.89084379 |
| 72 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87536132 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85994289 |
| 74 | * Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.85184492 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83368183 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82854914 |
| 77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82494769 |
| 78 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81422931 |
| 79 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.80130327 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78904533 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78569322 |
| 82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76741154 |
| 83 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.76721533 |
| 84 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.76051265 |
| 85 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.75846363 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.75159651 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.74082479 |
| 88 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.73038293 |
| 89 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72225412 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72168512 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.71959278 |
| 92 | Base excision repair_Homo sapiens_hsa03410 | 0.71377349 |
| 93 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.71115774 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70487447 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70393997 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.69123564 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68674308 |
| 98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66639540 |
| 99 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.66549683 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.65367024 |
| 101 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.65346933 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64943766 |
| 103 | Hepatitis B_Homo sapiens_hsa05161 | 0.64195197 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.62721599 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.62520667 |
| 106 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62293931 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60536976 |
| 108 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.60258246 |
| 109 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59971813 |
| 110 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58464733 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58375668 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57013776 |
| 113 | RNA degradation_Homo sapiens_hsa03018 | 0.56916153 |
| 114 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56432624 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56104776 |
| 116 | Measles_Homo sapiens_hsa05162 | 0.55238285 |
| 117 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.55052258 |
| 118 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54847595 |
| 119 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54115400 |
| 120 | Legionellosis_Homo sapiens_hsa05134 | 0.53608178 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53141609 |
| 122 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52050644 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.51285339 |
| 124 | Hepatitis C_Homo sapiens_hsa05160 | 0.51104289 |
| 125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.50781006 |
| 126 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50596532 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.50244630 |
| 128 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.50228306 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.49782992 |
| 130 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.49098101 |
| 131 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.49007374 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | 0.48859358 |
| 133 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47965262 |
| 134 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45846641 |
| 135 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.44745044 |
| 136 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43370988 |
| 137 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.40145429 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37991565 |
| 139 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33545524 |
| 140 | Adherens junction_Homo sapiens_hsa04520 | 0.33326475 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.32781032 |
| 142 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.29052494 |
| 143 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.24788188 |
| 144 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.21608480 |
| 145 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.19649089 |
| 146 | Galactose metabolism_Homo sapiens_hsa00052 | 0.19251209 |
| 147 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.18872690 |
| 148 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18798900 |
| 149 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.17205349 |
| 150 | Bladder cancer_Homo sapiens_hsa05219 | 0.16671486 |
| 151 | Circadian rhythm_Homo sapiens_hsa04710 | 0.16653130 |
| 152 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.16601350 |
| 153 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.16156161 |
| 154 | Melanoma_Homo sapiens_hsa05218 | 0.16092730 |
| 155 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.15459902 |
| 156 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15455080 |
| 157 | Prostate cancer_Homo sapiens_hsa05215 | 0.15087179 |

